LOW-VOLUME · HOSP-HEAVY
tigecycline Side Effects
tigecycline (also sold as Tygacil) is a LOW-VOLUME FAERS extract #381 of 524 by FAERS report count. Still opens on HOSP-HEAVY: 40.2% mention hospitalization (2,363 reports).
Data updated 2026-05-15
- 5,878
- FAERS reports
Thinner FAERS book - still a temporal association ledger, not proof of cause. Methodology.
tigecycline: 40.2% mention hospitalization (2,363 reports). Death stamp DEATH-HEAVY; volume band LOW-VOLUME #381 of 524 by FAERS report count.
Thinner FAERS extract for tigecycline (Tygacil) (5,878 reports #381 of 524 by FAERS report count). 40.2% mention hospitalization (2,363 reports). Sparse books still carry named reaction rows when present; not medical advice.
Counts from the openFDA FAERS extract (2005–2025). Stamps WATCHLIST · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
NAUSEA leads 390 of 5,878 reports
Who reports · age peak 45-64 (SEX-BALANCED)
Sex coding · SEX-BALANCED
Age peak 45-64 (1,376 reports)
FAERS filings rising toward 2025
Reactions in Death Reports
Death-mentioned subset is HEAVY here (1,597 reports, 27.2%). Top co-reported reactions in that subset - voluntary, not causal.
| Reaction | Reports |
|---|---|
| DEATH | 252 |
| SEPTIC SHOCK | 176 |
| SEPSIS | 160 |
| MULTIPLE ORGAN DYSFUNCTION SYNDROME | 98 |
| THROMBOCYTOPENIA | 92 |
| PATHOGEN RESISTANCE | 85 |
| MULTI-ORGAN FAILURE | 76 |
| TREATMENT FAILURE | 75 |
| PNEUMONIA | 70 |
| CONDITION AGGRAVATED | 65 |
| DRUG RESISTANCE | 60 |
| KLEBSIELLA INFECTION | 58 |
| RESPIRATORY FAILURE | 58 |
| HYPOTENSION | 57 |
| NEUTROPENIA | 50 |
| RENAL FAILURE | 49 |
| DRUG INEFFECTIVE FOR UNAPPROVED INDICATION | 47 |
| ACUTE KIDNEY INJURY | 45 |
Reactions in Hospitalization Reports
Hospitalization is HEAVY (2,363, 40.2% of the book). Top reactions in those rows:
| Reaction | Reports |
|---|---|
| THROMBOCYTOPENIA | 156 |
| NAUSEA | 149 |
| SEPSIS | 139 |
| SEPTIC SHOCK | 119 |
| VOMITING | 118 |
| DIARRHOEA | 112 |
| PYREXIA | 103 |
| PANCREATITIS ACUTE | 95 |
| PNEUMONIA | 85 |
| ACUTE KIDNEY INJURY | 82 |
| CONDITION AGGRAVATED | 80 |
| PANCREATITIS | 76 |
| DRUG RESISTANCE | 72 |
| HYPOTENSION | 72 |
| PATHOGEN RESISTANCE | 72 |
| ANAEMIA | 71 |
| COAGULOPATHY | 71 |
| DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS | 71 |
How to read tigecycline FAERS figures (WATCHLIST · DEATH-HEAVY · HOSP-HEAVY)
FAERS holds 5,878 voluntary reports linked to tigecycline (Tygacil), 2005-2025. Death is listed on 1,597 (27.2%). Hospitalization appears on 2,363 (40.2%). Top co-reported indication: Product Used For Unknown Indication.
Sparse extract - named reactions and SEX-BALANCED skew still differ by drug; not a complete safety profile.
Read with tigecycline
Peers ranked by ABS(total_reports), then an ABS(death_share) pole; guide hop follows DEATH-HEAVY · HOSP-HEAVY stamps.
ABS(total_reports) peer at 5,880 FAERS cases (Δ 2 heavier vs tigecycline); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's WATCHLIST · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
ABS(total_reports) peer at 5,840 FAERS cases (Δ 38 lighter vs tigecycline); DEATH-MARKED · HOSP-MID · SEX-BALANCED vs this page's WATCHLIST · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
ABS(total_reports) peer at 5,825 FAERS cases (Δ 53 lighter vs tigecycline); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's WATCHLIST · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
ABS(total_reports) peer at 5,936 FAERS cases (Δ 58 heavier vs tigecycline); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's WATCHLIST · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
ABS(death_share) pole at 62.1% death-mentioned reports (Δ 34.9 pp vs tigecycline's DEATH-HEAVY): CASELOAD · HOSP-MID.
tigecycline stamps DEATH-HEAVY · HOSP-HEAVY; FAERS outcome shares are signal-detection rates, not incidence. Read them next to caseload WATCHLIST and the label guide.